Vanda Pharmaceuticals Inc (VNDA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.60
• Market Cap: $489.41M
• EPS: $-3.74
• 52-Week High: $9.60
• 52-Week Low: $3.81

Market Sentiment

Vanda Pharmaceuticals Inc currently has a Bullish sentiment score of 0.47.

About Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Washington, D.C., dedicated to developing and commercializing innovative therapies aimed at addressing significant unmet medical needs in various therapeutic areas, including central nervous system disorders and sleep disorders. With a strong commitment to advancing patient care and a robust pipeline, Vanda leverages its scientific expertise to deliver transformative solutions to patients and healthcare providers alike...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Vanda Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VNDA pay dividends?

Vanda Pharmaceuticals Inc (VNDA) does not currently pay a regular dividend.

What is VNDA's market cap?

Vanda Pharmaceuticals Inc (VNDA) has a market capitalization of $489.41M with a current stock price of $8.60.